Amyloid burden and metabolic function in early-onset Alzheimer's disease: Parietal lobe involvement

Brain

Volumn 135, Issue 7, 2012, Pages 2115-2125

  Ossenkoppele, Rik ^a,b   Zwan, Marissa D ^a,b   Tolboom, Nelleke ^a,b   Van Assema, Danielle M E ^a,b   Adriaanse, Sofie F ^a,b   Kloet, Reina W ^b   Boellaard, Ronald ^b   Windhorst, Albert D ^b   Barkhof, Frederik ^b   Lammertsma, Adriaan A ^b   Scheltens, Philip ^a   Van Der Flier, Wiesje M ^a,b   Van Berckel, Bart N M ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Early onset; PET

Indexed keywords

AMYLOID; FLUORODEOXYGLUCOSE F 18; GLUCOSE; PITTSBURGH COMPOUND B;

ADULT; ALZHEIMER DISEASE; ARTICLE; ATTENTION; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; FRONTAL CORTEX; GLUCOSE METABOLISM; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCIPITAL CORTEX; PARIETAL CORTEX; PARIETAL LOBE; POSTERIOR CINGULATE; PRIORITY JOURNAL; TEMPORAL CORTEX; VISION; VISUAL IMPAIRMENT;

EID: 84863197449     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws113     Document Type: Article

References (57)

1. Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 1998; 55: 326-35. (Pubitemid 28146197)
2. Bigio EH, Hynan LS, Sontag E, Satumtira S, White CL. Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis. Neuropathol Appl Neurobiol 2002; 28: 218-27. (Pubitemid 34639444)
3. Bouwman FH, Schoonenboom NSM, Verwey NA, Van Elk E-J, Kok A, Blankenstein MA, et al. CSF biomarker levels in early and late onset Alzheimer's disease. Neurobiol Aging 2009; 30: 1895-901.
4. Brix G, Zaers J, Adam LE, Bellemann ME, Ostertag H, Trojan H, et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. J Nucl Med 1997; 38: 1614-23. (Pubitemid 27443965)
5. Buckner RL, Snyder AZ, Shannon BJ, LaRossa GN, Sachs R, Fotenos AF, et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid and memory. J Neurosci 2005; 25: 7709-17. (Pubitemid 41208641)
6. Choo IH, Lee DY, Kim JW, Seo EH, Lee DS, Kim SG, et al. Relationship of amyloid-beta burden with age-at-onset in Alzheimer disease. Am J Geriatr Psychiatry 2011; 19: 627-34.
7. Corbetta M, Shulman GL. Control of goal-directed and stimulus-driven attention in the brain. Nat Rev Neurosci 2002; 3: 201-15. (Pubitemid 135706590)
8. Cummings JL. Alzheimer's disease. N Engl J Med 2004; 351: 56-67.
9. de Souza LC, Corlier F, Habert MO, Uspenskaya O, Maroy R, Lamari F, et al. Similar amyloid-B burden in posterior cortical atrophy and Alzheimer's disease. Brain 2011; 134: 2036-43.
10. de Waal H, Stam CJ, Blankenstein MA, Pijnenburg YAL, Scheltens P, van der Flier WM. EEG abnormalities in early and late onset Alzheimer's disease: understanding heterogeneity. J Neurol Neurosurg Psychiatry 2011; 82: 67-71.
11. Devanand DP, Mikhno A, Pelton GH, Cuasay K, Pradhaban G, Dileep Kumar JS, et al. Pittsburgh compound-B (11C)PIB and fluorodeoxyglucose (18F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment and healthy controls. J Geriatr Psychiatry Neurol 2010; 23: 185-98.
12. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's disease and normal aging. AJR Am J Roentgenol 1987; 149: 351-6. (Pubitemid 17104996)
13. Forster S, Grimmer T, Miederer I, Henriksen G, Yousefi BH, Graner P, et al. Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delay. Biol Psychiatry 2011; 71: 392-7.
14. Fratiglioni L, Launer LJ, Andersen K, Breteler MMB, Copeland JR, Dartiques JF, et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology 2000; 54: S10-5. (Pubitemid 30390599)
15. Frisoni GB, Pievani M, Testa C, Sabattoli F, Bresciani L, Bonetti M, et al. The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain 2007; 130: 720-30. (Pubitemid 46410740)
16. Hansen LA, DeTeresa R, Davies P, Terry RD. Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease. Neurology 1988; 38: 48-54. (Pubitemid 18028091)
17. Hardy JA, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 197: 353-6. (Pubitemid 34790756)
18. Hedden T, Van Dijk KRA, Becker JA, Mehta A, Sperling RA, Johnson KA, et al. Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci 2009; 29: 12686-94.
19. Ho GJ, Hansen LA, Alford MF, Foster K, Salmon DP, Galasko D, et al. Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease. Neuroreport 2002; 13: 1825-8. (Pubitemid 35333171)
20. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010; 9: 119-28.
21. Jagust WJ, Reed BR, Seab JP, Budinger TF. Alzheimer's disease: age at onset and single-photon emission computed tomographic patterns of regional cerebral blood flow. Arch Neurol 1990; 47: 628-33. (Pubitemid 20183568)
22. Karas G, Scheltens P, Rombouts S, van Schijndel R, Klein M, Jones B, et al. Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study. Neuroradiology 2007; 49: 967-76. (Pubitemid 350159837)
23. Kemp PM, Holmes C, Hoffman SM, Bolt L, Holmes R, Rowden J, et al. Alzheimer's disease: differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementia. J Neurol Neurosurg Psychiatry 2003; 74: 715-9. (Pubitemid 36628280)
24. Kim EJ, Cho SS, Jeong Y, Park KC, Kang SJ, Kang E, et al. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients. Brain 2005; 128: 1790-801. (Pubitemid 41373650)
25. Kloet RW, Berckel BNM, Pouwels PJW, Schuitemaker A, Barkhof F, Kropholler MA, et al. Effects of MR scanner type, scanning sequence and segmentation algorithm on MR-based partial volume corrections of [11C](R)-PK11195 studies. NeuroImage 2006; (Suppl 2): T83.
26. Klunk WE, Engler H, Nordberg A, Wang Yanming, Blomquist G, Holt Daniel P, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol 2004; 55: 306-19. (Pubitemid 38269583)
27. Koedam ELGE, Lauffer V, van der Vlies AE, Flier WM, Scheltens P, Pijnenburg YAL. Early- versus late-onset Alzheimer's disease: more than age alone. J Alzheimer's Dis 2010; 19: 1401-8.
28. Koss E, Edland S, Fillenbaum G, Mohs R, Clark C, Galasko D, et al. Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: A CERAD analysis, part XII. Neurology 1996; 46: 136-41. (Pubitemid 26156118)
29. Leyton CE, Villemagne VL, Savage G, Pike K, Ballard CG, Piquet KJ, et al. Subtypes of progressive aphasia: application of the international consensus criteria and validation using B-amyloid imaging. Brain 2011; 134: 3030-43.
30. Lindeboom J, Matto D. [Digit series and Knox cubes as concentration tests for elderly subjects]. Tijdschrift voor Gerontologie en Geriatrie 1994; 25: 63-8.
31. Lindeboom J, Schmand B, Tulner L, Walstra G, Jonker C. Visual association test to detect early dementia of the Alzheimer type. Journal of Neurol Neurosurg Psychiatry 2002; 73: 126-33.
32. Luteijn F, van der Ploeg GIT. Groninger Intelligentie Test (in Dutch). Lisse: Swets & Zeitlinger; 1982.
33. Mann DM, Yates PO, Marcyniuk B. Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes. Neuropathol Appl Neurobiol 1984; 10: 185-207. (Pubitemid 14121330)
34. Marshall GA, Fairbanks LA, Tekin S, Vinters HV, Cummings J. Early-onset Alzheimer's disease is associated with greater pathological burden. J Geriatr Psychiatry Neurol 2007; 20: 29-33. (Pubitemid 46233616)
35. McKhann G, Knopman D, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dementia 2011; 7: 263-9.
36. Osterrieth PA. Le test de copie dúne figure complexe: contribution a l'etude de l'aperception et de la memoire. Archives de Psychologie 1944; 30: 205-353.
37. Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O'Neill JP, Janabi M, et al. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain 2010; 133: 512-28.
38. Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, et al. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 2008; 64: 388-401.
39. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Schulman GL. A default mode of brain function. Proc Natl Acad Sci 2001; 98: 676-82. (Pubitemid 32105102)
40. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958; 8: 271-6.
41. Rosenbloom MH, Alkalay A, Agarwal N, Baker SL, O'Neill JP, Janabi M, et al. Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology 2011; 76: 1789-96.
42. Saan RJ, Deelman BG. De 15-Woorden test A en B (Een voorlopige handleiding, in Dutch). 1986.
43. Sakamoto S, Ishii K, Sasaki M, Hosaka K, Mori T, Matsui M, et al. Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease. J Neurol Sci 2002; 200: 27-32. (Pubitemid 34792738)
44. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al. Atrophy of medial temporal lobes on MRI in "probable"Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992; 55: 967-72.
45. Soininen H, Helkala E, Kuikka J, Hartikainen P, Lehtovirta M, Riekinnen P. Regional cerebral blood flow measured by 99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease. J Neural Transm Park Dis Dem Sect 1995; 9: 95-109.
46. Stopford CL, Snowden JS, Thompson JC, Neary D. Variability in cognitive presentation of Alzheimer's disease. Cortex 2008; 44: 185-95. (Pubitemid 351729233)
47. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935; 18: 643-62.
48. Svarer C, Madsen K, Hasselbalch SG, Pinborg LH, Haugbol S, Frokjaer VG, et al. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. NeuroImage 2005; 24: 969-79. (Pubitemid 40164499)
49. Tolboom N, Yaqub M, van der Flier WM, Boellaard R, Luurtsema G, Windhorst AD, et al. Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET. J Nucl Med 2009; 50: 191-7.
50. Verhage F. In: Van Gorcum, editor. Intelligentie en leeftijd: onderzoek bij Nederlanders van twaalf tot zevenenzeventig jaar [Intelligence and age: study with Dutch people aged 12 to 77]. Assen, 1964.
51. Vincent JL, Kahn I, Snyder AZ, Raichle ME, Buckner RL. Evidence for a frontoparietal control system revealed by intrinsic functional connectivity. J Neurophysiol 2008; 100: 3328-42.
52. Warrington EK, James M. The visual object and space perception battery. Bury St. Edmunds UK: Thames Valley test company; 1991.
53. Wilson AA, Garcia A, Chestaskova A, Kung HF, Houle S. A rapid one-step radiosynthesis of the beta-amyloid imaging radiotracer N-methyl-[C-11]2- (′4-methylaminophenyl)-6-hydroxybenzothiazole ([C-11]-6-OH-BTA-1). J Labelled Compd Radiopharm 2004; 47: 679-82. (Pubitemid 39390042)
54. Wu Y, Carson R. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J Cereb Blood Flow Metab 2002; 22: 1440-52. (Pubitemid 35424928)
55. Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Nakazato Y. Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain. Acta Neuropathology 1989; 77: 314-9. (Pubitemid 19044199)
56. Yaqub M, Tolboom N, Boellaard R, van Berckel BNM, van Tilburg EW, Luurtsema G, et al. Simplified parametric methods for [11C]PIB studies. NeuroImage 2008; 42: 76-86.
57. Yasuno F, Imamura T, Hirono N, Ishii K, Sasaki M, Ikejiri Y, et al. Age at onset and regional cerebral glucose metabolism in Alzheimer's disease. Dement Geriatr Cogn Disord 1998; 9: 63-7. (Pubitemid 28081685)